Search

Author/Creator Melear, Jason M.

1. A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer. (January 2022)

Authors:
Plummer, Ruth; Dean, Emma; Arkenau, Hendrik-Tobias; Redfern, Charles; Spira, Alexander I.; Melear, Jason M.; Chung, Ki Y.; Ferrer-Playan, Jordi; Goddemeier, Thomas; Locatelli, Giuseppe; Dong, Jennifer; Fleuranceau-Morel, Patricia; Diaz-Padilla, Ivan; Shapiro, Geoffrey I.
Journal:
Lung cancer
Issue:
Volume 163(2022)
Page Start:
19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase 1/2 study of acalabrutinib and the PI3K delta inhibitor ACP-319 in relapsed/refractory B-cell Non-Hodgkin lymphoma. Issue 7 (7th June 2022)

Authors:
Barr, Paul M.; Smith, Stephen D.; Roschewski, Mark J.; O'Brien, Susan M.; Sharman, Jeff P.; Melear, Jason M.; Patel, Priti; Calvo, Roser; Yang, Helen; Spurgeon, Stephen E.
Journal:
Leukemia & lymphoma
Issue:
Volume 63:Issue 7(2022)
Page Start:
1728
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search